| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164.
|
| [3] |
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020版)[J]. 中华消化外科杂志, 2020, 19(6): 563-88.
|
| [4] |
中国医师协会结直肠肿瘤专业委员会, 中国抗癌协会大肠癌专业委员会, 国家癌症中心国家肿瘤质控中心结直肠癌质控专家委员会. 结直肠癌靶向治疗中国专家共识[J/CD]. 中华普通外科学文献（电子版）, 2023, 17(1): 1-8.
|
| [5] |
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: A systematic review and meta-analysis[J]. Ann Surg, 2018, 267(6): 1047-1055.
|
| [6] |
Hamady ZZ, Lodge JP, Welsh FK, et al. One-millimeter cancer-free margin is curative for colorectal liver metastases: A propensity score case-match approach[J]. Ann Surg, 2014, 259(3): 543-548.
|
| [7] |
Lauwerends LJ, van Driel P, Baatenburg de Jong RJ, et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery[J]. Lancet Oncol, 2021, 22(5): e186-e195.
|
| [8] |
Smith AM, Mancini MC, Nie S. Bioimaging: second window for in vivo imaging[J]. Nat Nanotechnol, 2009, 4(11): 710-711.
|
| [9] |
Goi T, Fujioka M, Satoh Y, et al. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor[J]. Cancer Res, 2004, 64(6): 1906-1910.
|
| [10] |
Freire Valls A, Knipper K, Giannakouri E, et al. VEGFR1+ metastasis-associated macrophages contribute to metastatic angiogenesis and influence colorectal cancer patient outcome[J]. Clin Cancer Res, 2019, 25(18): 5674-5685.
|
| [11] |
Boogerd L, Hoogstins C, Schaap DP, et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: A dose-escalation pilot study[J]. Lancet Gastroenterol Hepatol, 2018, 3(3): 181-191.
|
| [12] |
de Gooyer JM, Elekonawo F, Bremers A, et al. Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin[J]. Nat Commun, 2022, 13(1): 2621.
|
| [13] |
Li F, Zhang Z, Cai J, et al. Primary preclinical and clinical evaluation of (68)Ga-DOTA-TMVP1 as a novel VEGFR-3 PET imaging radiotracer in gynecological cancer[J]. Clin Cancer Res, 2020, 26(6): 1318-1326.
|
| [14] |
Fleetwood F, Klint S, Hanze M, et al. Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic affibody molecules results in dramatically improved affinity[J]. Sci Rep, 2014, 4: 7518.
|
| [15] |
Hu Z, Fang C, Li B, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-Ⅰ/Ⅱ windows[J]. Nat Biomed Eng, 2020, 4(3): 259-271.
|